HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Meta-Analysis on NeuroAiD’s Role in Stroke Recovery to Be Featured at ASNA 2025

We are pleased to highlight a featured poster presented by Dr. N. V. Ramani, Chair of the Asian Stroke Advisory Panel (ASAP), at the upcoming ASEAN Neurological Association (ASNA) 2025 conference.

? Poster Title: “Meta-Analysis of Effect of MLC601/MLC901 on Motor Recovery after Stroke”
? Presenter: Dr. N. V. Ramani
? Date: 8–10 August 2025
? Location: Bali, Indonesia

This presentation offers a comprehensive meta-analysis of motor recovery outcomes from multiple clinical trials on NeuroAiD (MLC601/MLC901) in stroke patients, reflecting its role in enhancing post-stroke rehabilitation.

We encourage clinicians, researchers, and stroke care professionals to attend the presentation in Bali.

More on ASNA 2025: https://asna-indonesia-2025.com/
More on ASAP: https://www.asianstrokeadvisory.com/
More on NeuroAiD: www.neuroaid.com